Skip to main content
Top
Published in: BMC Health Services Research 1/2017

Open Access 01-12-2017 | Study protocol

The impact of community health worker-led home delivery of antiretroviral therapy on virological suppression: a non-inferiority cluster-randomized health systems trial in Dar es Salaam, Tanzania

Authors: Pascal Geldsetzer, Joel M. Francis, Nzovu Ulenga, David Sando, Irene A. Lema, Eric Mboggo, Maria Vaikath, Happiness Koda, Sharon Lwezaula, Janice Hu, Ramadhani A. Noor, Ibironke Olofin, Elysia Larson, Wafaie Fawzi, Till Bärnighausen

Published in: BMC Health Services Research | Issue 1/2017

Login to get access

Abstract

Background

Home delivery of antiretroviral therapy (ART) by community health workers (CHWs) may improve ART retention by reducing the time burden and out-of-pocket expenditures to regularly attend an ART clinic. In addition, ART home delivery may shorten waiting times and improve quality of care for those in facility-based care by decongesting ART clinics. This trial aims to determine whether ART home delivery for patients who are clinically stable on ART combined with facility-based care for those who are not stable on ART is non-inferior to the standard of care (facility-based care for all ART patients) in achieving and maintaining virological suppression.

Methods

This is a non-inferiority cluster-randomized trial set in Dar es Salaam, Tanzania. A cluster is one of 48 healthcare facilities with its surrounding catchment area. 24 clusters were randomized to ART home delivery and 24 to the standard of care. The intervention consists of home visits by CHWs to provide counseling and deliver ART to patients who are stable on ART, while the control is the standard of care (facility-based ART and CHW home visits without ART home delivery). In addition, half of the healthcare facilities in each study arm were randomized to standard counseling during home visits (covering family planning, prevention of HIV transmission, and ART adherence), and half to standard plus nutrition counseling (covering food production and dietary advice). The non-inferiority design applies to the endpoints of the ART home delivery trial; the primary endpoint is the proportion of ART patients at a healthcare facility who are virally suppressed at the end of the study period. The margin of non-inferiority for this primary endpoint was set at nine percentage points.

Discussion

As the number of ART patients in sub-Saharan Africa is expected to rise, this trial provides causal evidence on the effectiveness of a home-based care model that could decongest ART clinics and reduce patients’ healthcare expenditures. More broadly, this trial will inform the increasing policy interest in task-shifting of chronic disease care from facility- to community-based healthcare workers.

Trial registration

ClinicalTrials.gov: NCT02711293. Registration date: 16 March 2016.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization. World Health Statistics 2015. Geneva: World Health Organization; 2015. World Health Organization. World Health Statistics 2015. Geneva: World Health Organization; 2015.
2.
go back to reference UNAIDS. AIDS by the numbers 2015. Geneva: UNAIDS; 2015. UNAIDS. AIDS by the numbers 2015. Geneva: UNAIDS; 2015.
3.
go back to reference World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. Geneva: WHO; 2006. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. Geneva: WHO; 2006.
4.
go back to reference World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. Geneva: WHO; 2010. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. Geneva: WHO; 2010.
5.
go back to reference World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2013. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2013.
6.
go back to reference World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection - Recommendations for a public health approach. Secondth ed. Geneva: World Health Organization; 2016. p. 480. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection - Recommendations for a public health approach. Secondth ed. Geneva: World Health Organization; 2016. p. 480.
7.
go back to reference Hontelez J, Chang A, Ogbuoji O, Vlas S, Bärnighausen T, Atun R. Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: Investment needs, population health gains, and cost-effectiveness. AIDS. 2016;30(15):2341–350.CrossRefPubMedPubMedCentral Hontelez J, Chang A, Ogbuoji O, Vlas S, Bärnighausen T, Atun R. Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: Investment needs, population health gains, and cost-effectiveness. AIDS. 2016;30(15):2341–350.CrossRefPubMedPubMedCentral
8.
go back to reference Atun R, Chang A, Ogbuoji O, Sachin S, Resch S, Hontelez J, Bärnighausen T. Long term financing needs for HIV control in sub-Saharan Africa in 2015–2050: modelling study. BMJ Open. 2016;6(3):e009656.CrossRefPubMedPubMedCentral Atun R, Chang A, Ogbuoji O, Sachin S, Resch S, Hontelez J, Bärnighausen T. Long term financing needs for HIV control in sub-Saharan Africa in 2015–2050: modelling study. BMJ Open. 2016;6(3):e009656.CrossRefPubMedPubMedCentral
9.
go back to reference Ortego C, Huedo-Medina TB, Llorca J, Sevilla L, Santos P, Rodriguez E, Warren MR, Vejo J. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381–96.CrossRefPubMed Ortego C, Huedo-Medina TB, Llorca J, Sevilla L, Santos P, Rodriguez E, Warren MR, Vejo J. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381–96.CrossRefPubMed
10.
go back to reference Muya AN, Geldsetzer P, Hertzmark E, Ezeamama AE, Kawawa H, Hawkins C, Sando D, Chalamilla G, Fawzi W, Spiegelman D. Predictors of nonadherence to antiretroviral therapy among HIV-infected adults in Dar Es Salaam, Tanzania. J Int Assoc Provid AIDS Care. 2014;14(2):163–71.CrossRefPubMed Muya AN, Geldsetzer P, Hertzmark E, Ezeamama AE, Kawawa H, Hawkins C, Sando D, Chalamilla G, Fawzi W, Spiegelman D. Predictors of nonadherence to antiretroviral therapy among HIV-infected adults in Dar Es Salaam, Tanzania. J Int Assoc Provid AIDS Care. 2014;14(2):163–71.CrossRefPubMed
11.
go back to reference Press N, Tyndall MW, Wood E, Hogg RS, Montaner JS. Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2002;31 Suppl 3:S112–117.CrossRefPubMed Press N, Tyndall MW, Wood E, Hogg RS, Montaner JS. Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2002;31 Suppl 3:S112–117.CrossRefPubMed
12.
go back to reference Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L. Ann Intern Med. 2003;139(10):810–6.CrossRefPubMed Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L. Ann Intern Med. 2003;139(10):810–6.CrossRefPubMed
13.
go back to reference Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–3.CrossRefPubMed Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–3.CrossRefPubMed
14.
go back to reference Ware NC, Wyatt MA, Geng EH, Kaaya SF, Agbaji OO, Muyindike WR, Chalamilla G, Agaba PA. Toward an understanding of disengagement from HIV treatment and care in sub-Saharan Africa: a qualitative study. PLoS Med. 2013;10(1):e1001369. discussion e1001369.CrossRefPubMedPubMedCentral Ware NC, Wyatt MA, Geng EH, Kaaya SF, Agbaji OO, Muyindike WR, Chalamilla G, Agaba PA. Toward an understanding of disengagement from HIV treatment and care in sub-Saharan Africa: a qualitative study. PLoS Med. 2013;10(1):e1001369. discussion e1001369.CrossRefPubMedPubMedCentral
15.
go back to reference Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav. 2010;14(4):778–84.CrossRefPubMed Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav. 2010;14(4):778–84.CrossRefPubMed
16.
go back to reference Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Kglatwane J, Kinsman J, Kwasa R, Maridadi J, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19(5):658–65.CrossRefPubMed Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Kglatwane J, Kinsman J, Kwasa R, Maridadi J, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19(5):658–65.CrossRefPubMed
17.
go back to reference Meyer-Rath GRS. User fees, transport costs, and the ethics of exemption: how free is free ART? S Afr J HIV Med. 2007;8(2):52–6. Meyer-Rath GRS. User fees, transport costs, and the ethics of exemption: how free is free ART? S Afr J HIV Med. 2007;8(2):52–6.
18.
go back to reference Tomori C, Kennedy CE, Brahmbhatt H, Wagman JA, Mbwambo JK, Likindikoki S, Kerrigan DL. Barriers and facilitators of retention in HIV care and treatment services in Iringa, Tanzania: the importance of socioeconomic and sociocultural factors. AIDS Care. 2014;26(7):907–13.CrossRefPubMed Tomori C, Kennedy CE, Brahmbhatt H, Wagman JA, Mbwambo JK, Likindikoki S, Kerrigan DL. Barriers and facilitators of retention in HIV care and treatment services in Iringa, Tanzania: the importance of socioeconomic and sociocultural factors. AIDS Care. 2014;26(7):907–13.CrossRefPubMed
19.
go back to reference Lankowski AJ, Siedner MJ, Bangsberg DR, Tsai AC. Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review. AIDS Behav. 2014;18(7):1199–223.CrossRefPubMedPubMedCentral Lankowski AJ, Siedner MJ, Bangsberg DR, Tsai AC. Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review. AIDS Behav. 2014;18(7):1199–223.CrossRefPubMedPubMedCentral
20.
go back to reference Bärnighausen T, Bloom DE, Humair S. Human resources for treating HIV/AIDS: needs, capacities, and gaps. AIDS Patient Care STDS. 2007;21(11):799–812.CrossRefPubMed Bärnighausen T, Bloom DE, Humair S. Human resources for treating HIV/AIDS: needs, capacities, and gaps. AIDS Patient Care STDS. 2007;21(11):799–812.CrossRefPubMed
21.
go back to reference Wouters E, Van Damme W, Van Loon F, van Rensburg D, Meulemans H. Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome. Soc Sci Med. 2009;69(8):1177–85.CrossRefPubMed Wouters E, Van Damme W, Van Loon F, van Rensburg D, Meulemans H. Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome. Soc Sci Med. 2009;69(8):1177–85.CrossRefPubMed
22.
go back to reference World Health Organization. Task Shifting: rational redistribution of tasks among health workforce teams: global recommendations and guidelines. Geneva: WHO; 2008. World Health Organization. Task Shifting: rational redistribution of tasks among health workforce teams: global recommendations and guidelines. Geneva: WHO; 2008.
23.
go back to reference Lazarus JV, Safreed-Harmon K, Nicholson J, Jaffar S. Health service delivery models for the provision of antiretroviral therapy in sub-Saharan Africa: a systematic review. Trop Med Int Health. 2014;19(10):1198–215.CrossRefPubMed Lazarus JV, Safreed-Harmon K, Nicholson J, Jaffar S. Health service delivery models for the provision of antiretroviral therapy in sub-Saharan Africa: a systematic review. Trop Med Int Health. 2014;19(10):1198–215.CrossRefPubMed
24.
go back to reference Jaffar S, Amuron B, Foster S, Birungi J, Levin J, Namara G, Nabiryo C, Ndembi N, Kyomuhangi R, Opio A, et al. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet. 2009;374(9707):2080–9.CrossRefPubMedPubMedCentral Jaffar S, Amuron B, Foster S, Birungi J, Levin J, Namara G, Nabiryo C, Ndembi N, Kyomuhangi R, Opio A, et al. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet. 2009;374(9707):2080–9.CrossRefPubMedPubMedCentral
25.
go back to reference Amuron B, Levin J, Birunghi J, Namara G, Coutinho A, Grosskurth H, Jaffar S. Mortality in an antiretroviral therapy programme in Jinja, south-east Uganda: a prospective cohort study. AIDS Res Ther. 2011;8:39.CrossRefPubMedPubMedCentral Amuron B, Levin J, Birunghi J, Namara G, Coutinho A, Grosskurth H, Jaffar S. Mortality in an antiretroviral therapy programme in Jinja, south-east Uganda: a prospective cohort study. AIDS Res Ther. 2011;8:39.CrossRefPubMedPubMedCentral
26.
go back to reference Kipp W, Konde-Lule J, Rubaale T, Okech-Ojony J, Alibhai A, Saunders DL. Comparing antiretroviral treatment outcomes between a prospective community-based and hospital-based cohort of HIV patients in rural Uganda. BMC Int Health Hum Rights. 2011;11 Suppl 2:S12.CrossRefPubMedPubMedCentral Kipp W, Konde-Lule J, Rubaale T, Okech-Ojony J, Alibhai A, Saunders DL. Comparing antiretroviral treatment outcomes between a prospective community-based and hospital-based cohort of HIV patients in rural Uganda. BMC Int Health Hum Rights. 2011;11 Suppl 2:S12.CrossRefPubMedPubMedCentral
27.
go back to reference Kipp W, Konde-Lule J, Saunders LD, Alibhai A, Houston S, Rubaale T, Senthilselvan A, Okech-Ojony J. Antiretroviral treatment for HIV in rural Uganda: two-year treatment outcomes of a prospective health centre/community-based and hospital-based cohort. PLoS One. 2012;7(7):e40902.CrossRefPubMedPubMedCentral Kipp W, Konde-Lule J, Saunders LD, Alibhai A, Houston S, Rubaale T, Senthilselvan A, Okech-Ojony J. Antiretroviral treatment for HIV in rural Uganda: two-year treatment outcomes of a prospective health centre/community-based and hospital-based cohort. PLoS One. 2012;7(7):e40902.CrossRefPubMedPubMedCentral
28.
go back to reference Selke HM, Kimaiyo S, Sidle JE, Vedanthan R, Tierney WM, Shen C, Denski CD, Katschke AR, Wools-Kaloustian K. Task-shifting of antiretroviral delivery from health care workers to persons living with HIV/AIDS: clinical outcomes of a community-based program in Kenya. J Acquir Immune Defic Syndr. 2010;55(4):483–90.CrossRefPubMed Selke HM, Kimaiyo S, Sidle JE, Vedanthan R, Tierney WM, Shen C, Denski CD, Katschke AR, Wools-Kaloustian K. Task-shifting of antiretroviral delivery from health care workers to persons living with HIV/AIDS: clinical outcomes of a community-based program in Kenya. J Acquir Immune Defic Syndr. 2010;55(4):483–90.CrossRefPubMed
29.
go back to reference Tanzania Commission for AIDS ZAC, National Bureau of Statistics, Office of the Chief Government Statistician, ICF International. Tanzania HIV/AIDS and Malaria Indicator Survey 2011–2012: Key Findings. 2013. Tanzania Commission for AIDS ZAC, National Bureau of Statistics, Office of the Chief Government Statistician, ICF International. Tanzania HIV/AIDS and Malaria Indicator Survey 2011–2012: Key Findings. 2013.
30.
go back to reference Chimbindi N, Bor J, Newell ML, Tanser F, Baltusen R, Hontelez J, de Vlas S, Lurie M, Pillay D, Bärnighausen T. Time and money: the true costs of health care utilization for patients receiving ‘free’ HIV/TB care and treatment in rural KwaZulu-Natal. J Acquir Immune Defic Syndr. 2015;70(2):e52–60.CrossRefPubMedPubMedCentral Chimbindi N, Bor J, Newell ML, Tanser F, Baltusen R, Hontelez J, de Vlas S, Lurie M, Pillay D, Bärnighausen T. Time and money: the true costs of health care utilization for patients receiving ‘free’ HIV/TB care and treatment in rural KwaZulu-Natal. J Acquir Immune Defic Syndr. 2015;70(2):e52–60.CrossRefPubMedPubMedCentral
31.
go back to reference Hemming K, Marsh J. A menu-driven facility for sample-size calculations in cluster randomized controlled trials. Stata J. 2013;13(1):114–35. Hemming K, Marsh J. A menu-driven facility for sample-size calculations in cluster randomized controlled trials. Stata J. 2013;13(1):114–35.
33.
go back to reference Mosha F, Ledwaba J, Ndugulile F, Ng'ang'a Z, Nsubuga P, Morris L, Kasubi M, Swai A, Vercauteren J, Vandamme AM. Clinical and virological response to antiretroviral drugs among HIV patients on first-line treatment in Dar-es-Salaam, Tanzania. J Infect Dev Ctries. 2014;8(7):845–52.CrossRefPubMed Mosha F, Ledwaba J, Ndugulile F, Ng'ang'a Z, Nsubuga P, Morris L, Kasubi M, Swai A, Vercauteren J, Vandamme AM. Clinical and virological response to antiretroviral drugs among HIV patients on first-line treatment in Dar-es-Salaam, Tanzania. J Infect Dev Ctries. 2014;8(7):845–52.CrossRefPubMed
34.
go back to reference Barnhart D, Hertzmark E, Liu E, Mungure E, Muya AN, Sando D, Chalamilla G, Ulenga N, Bärnighausen T, Fawzi W, Spiegelman D. Intra-Cluster Correlation Estimates for HIV-related Outcomes from Care and Treatment Clinics in Dar es Salaam, Tanzania. Contemp Clin Trials Commun. 2016;4:161–69.CrossRefPubMed Barnhart D, Hertzmark E, Liu E, Mungure E, Muya AN, Sando D, Chalamilla G, Ulenga N, Bärnighausen T, Fawzi W, Spiegelman D. Intra-Cluster Correlation Estimates for HIV-related Outcomes from Care and Treatment Clinics in Dar es Salaam, Tanzania. Contemp Clin Trials Commun. 2016;4:161–69.CrossRefPubMed
35.
go back to reference Alo C, Ogbonnaya LU, Azuogu BN. Effects of nutrition counseling and monitoring on the weight and hemoglobin of patients receiving antiretroviral therapy in Ebonyi State, Southeast Nigeria. HIV AIDS (Auckl). 2014;6:91–7. Alo C, Ogbonnaya LU, Azuogu BN. Effects of nutrition counseling and monitoring on the weight and hemoglobin of patients receiving antiretroviral therapy in Ebonyi State, Southeast Nigeria. HIV AIDS (Auckl). 2014;6:91–7.
36.
go back to reference Geldsetzer P, Fink G, Vaikath M, Bärnighausen T. Sampling for Patient Exit Interviews: Assessment of Methods Using Mathematical Derivation and Computer Simulations. Health Serv Res. 2016. doi:10.1111/1475-6773.12611. Geldsetzer P, Fink G, Vaikath M, Bärnighausen T. Sampling for Patient Exit Interviews: Assessment of Methods Using Mathematical Derivation and Computer Simulations. Health Serv Res. 2016. doi:10.​1111/​1475-6773.​12611.
37.
go back to reference Raykar NP, Bowder AN, Liu C, Vega M, Kim JH, Boye G, Greenberg SL, Riesel JN, Gillies RD, Meara JG, et al. Geospatial mapping to estimate timely access to surgical care in nine low-income and middle-income countries. Lancet. 2015;385 Suppl 2:S16.CrossRefPubMed Raykar NP, Bowder AN, Liu C, Vega M, Kim JH, Boye G, Greenberg SL, Riesel JN, Gillies RD, Meara JG, et al. Geospatial mapping to estimate timely access to surgical care in nine low-income and middle-income countries. Lancet. 2015;385 Suppl 2:S16.CrossRefPubMed
39.
go back to reference Brundisini F, Giacomini M, DeJean D, Vanstone M, Winsor S, Smith A. Chronic disease patients’ experiences with accessing health care in rural and remote areas: a systematic review and qualitative meta-synthesis. Ont Health Technol Assess Ser. 2013;13(15):1–33. Brundisini F, Giacomini M, DeJean D, Vanstone M, Winsor S, Smith A. Chronic disease patients’ experiences with accessing health care in rural and remote areas: a systematic review and qualitative meta-synthesis. Ont Health Technol Assess Ser. 2013;13(15):1–33.
40.
go back to reference Pell C, Straus L, Andrew EV, Menaca A, Pool R. Social and cultural factors affecting uptake of interventions for malaria in pregnancy in Africa: a systematic review of the qualitative research. PLoS One. 2011;6(7):e22452.CrossRefPubMedPubMedCentral Pell C, Straus L, Andrew EV, Menaca A, Pool R. Social and cultural factors affecting uptake of interventions for malaria in pregnancy in Africa: a systematic review of the qualitative research. PLoS One. 2011;6(7):e22452.CrossRefPubMedPubMedCentral
41.
go back to reference Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800.CrossRefPubMedCentral Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800.CrossRefPubMedCentral
42.
go back to reference Fox MP, Rosen S. Retention of adult patients on antiretroviral therapy in low- and middle-income countries: systematic review and meta-analysis 2008–2013. J Acquir Immune Defic Syndr. 2015;69(1):98–108.CrossRefPubMedPubMedCentral Fox MP, Rosen S. Retention of adult patients on antiretroviral therapy in low- and middle-income countries: systematic review and meta-analysis 2008–2013. J Acquir Immune Defic Syndr. 2015;69(1):98–108.CrossRefPubMedPubMedCentral
43.
go back to reference Woodd SL, Grosskurth H, Levin J, Amuron B, Namara G, Birunghi J, Coutinho A, Jaffar S. Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4(+) cell counts: findings from a cluster-randomized trial. AIDS. 2014;28(4):569–76.PubMedPubMedCentral Woodd SL, Grosskurth H, Levin J, Amuron B, Namara G, Birunghi J, Coutinho A, Jaffar S. Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4(+) cell counts: findings from a cluster-randomized trial. AIDS. 2014;28(4):569–76.PubMedPubMedCentral
Metadata
Title
The impact of community health worker-led home delivery of antiretroviral therapy on virological suppression: a non-inferiority cluster-randomized health systems trial in Dar es Salaam, Tanzania
Authors
Pascal Geldsetzer
Joel M. Francis
Nzovu Ulenga
David Sando
Irene A. Lema
Eric Mboggo
Maria Vaikath
Happiness Koda
Sharon Lwezaula
Janice Hu
Ramadhani A. Noor
Ibironke Olofin
Elysia Larson
Wafaie Fawzi
Till Bärnighausen
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2017
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-017-2032-7

Other articles of this Issue 1/2017

BMC Health Services Research 1/2017 Go to the issue